21 CFR 522.1850 - Polysulfated glycosaminoglycan.

§ 522.1850 Polysulfated glycosaminoglycan.


(1) Each 1-milliliter (mL) ampule of solution contains 250 milligrams (mg) polysulfated glycosaminoglycan.

(2) Each mL of solution packaged in 5-mL ampules or 20-, 30-, or 50-mL vials contains 100 mg polysulfated glycosaminoglycan.

(b)Sponsor. See No. 010797 in § 510.600(c) of this chapter.

(c)Special considerations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

(d)Conditions of use -

(1)Horses -

(i)Indications for use. For the treatment of noninfectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.

(ii)Amount -

(A)Intra-articular use (carpal): 250 mg once a week for 5 weeks.

(B)Intramuscular use (carpal and hock): 500 mg every 4 days for 28 days.

(iii)Limitations. Do not use in horses intended for human consumption.

(2)Dogs -

(i)Indications for use. For control of signs associated with noninfectious degenerative and/or traumatic arthritis of canine synovial joints.

(ii)Amount. 2 mg per pound of body weight by intramuscular injection twice weekly for up to 4 weeks (maximum of 8 injections).

[ 72 FR 56896, Oct. 5, 2007, as amended at 74 FR 67816, Dec. 21, 2009]

This is a list of United States Code sections, Statutes at Large, Public Laws, and Presidential Documents, which provide rulemaking authority for this CFR Part.

This list is taken from the Parallel Table of Authorities and Rules provided by GPO [Government Printing Office].

It is not guaranteed to be accurate or up-to-date, though we do refresh the database weekly. More limitations on accuracy are described at the GPO site.

United States Code
U.S. Code: Title 21 - FOOD AND DRUGS